Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2020 Financial Results on May 11, 2020


Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the first quarter of fiscal year 2020 will be released before the market opens on Monday, May 11.

Management will host a conference call at 8:00 a.m. Eastern Time on May 11 to discuss the results of the quarter and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13701491. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company's website and at:

https://78449.themediaframe.com/dataconf/productusers/apyx/mediaframe/36949/indexl.html.

A telephonic replay will be available approximately two hours after the end of the call through May 25, 2020. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13701491. The webcast will be archived on the Investor Relations section of the Company's website.

About Apyx Medical Corporation:

Apyx Medical Corporation (formerly Bovie Medical Corporation) is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company's Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion® offers plastic surgeons, fascial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma® system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.


These press releases may also interest you

at 08:08
Real estate marketplace Point2 reached a new traffic milestone in May, recording 13 million visits. Formerly known as Point2 Homes and covering the homes for sale niche, the platform has extended its business by developing its rental and commercial...

at 08:05
Movado Group, Inc. invites investors to listen to a broadcast of the Company's conference call to discuss first quarter fiscal year 2021 earnings results on Tuesday, June 9, 2020 at 9:00 a.m. Eastern Time. A press release detailing the Company's...

at 08:05
The cost of homeowners insurance has risen considerably in recent years, and will continue to rise in 2020 according to a new report from ValuePenguin.com by LendingTree . In 2010, the average annual cost of homeowners insurance across the country...

at 08:05
The Town of Hull announced it has joined the Massachusetts Purchasing Group and will be publishing and distributing upcoming bid opportunities on the system. BidNet's Massachusetts Purchasing Group connects participating agencies from across...

at 08:05
Real estate marketplace Point2 (formerly known as Point2 Homes) not only reached a new traffic milestone of 13 million visits in May, but also...

at 08:04
The following issues have been halted by IIROC: Company: Algernon Pharmaceuticals Inc. CSE Symbol: AGN (all issues) Reason: At the request of the Company Pending News Halt Time (ET): 7:52 AM IIROC can make a decision to impose a temporary suspension...



News published on 7 april 2020 at 09:30 and distributed by: